Pharming (PHAR) Current Leases (2019 - 2025)
Pharming's Current Leases history spans 7 years, with the latest figure at $3.4 million for Q4 2025.
- Quarterly results put Current Leases at $3.4 million for Q4 2025, up 14.36% from a year ago — trailing twelve months through Dec 2025 was $3.4 million (up 14.36% YoY), and the annual figure for FY2025 was $3.4 million, up 14.36%.
- Current Leases for Q4 2025 was $3.4 million at Pharming, up from $2.9 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $3.6 million in Q4 2023 to a low of $2.4 million in Q4 2021.
- The 5-year median for Current Leases is $3.4 million (2025), against an average of $3.2 million.
- The sharpest move saw Current Leases surged 43.24% in 2022, then decreased 18.53% in 2024.
- Year by year, Current Leases stood at $2.4 million in 2021, then surged by 43.24% to $3.5 million in 2022, then rose by 4.36% to $3.6 million in 2023, then fell by 18.53% to $2.9 million in 2024, then rose by 14.36% to $3.4 million in 2025.
- According to Business Quant data, Current Leases over the past three periods came in at $3.4 million, $2.9 million, and $3.6 million for Q4 2025, Q4 2024, and Q4 2023 respectively.